Art. 29 Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…

Submission and validation of applications

In forcecited 11×
1.

Applicants wishing to apply for a national authorisation in accordance with Article 17 shall submit an application to the receiving competent authority. The receiving competent authority shall inform the applicant of the fees payable under Article 80(2), and shall reject the application if the applicant fails to pay the fees within 30 days. It shall inform the applicant accordingly. Upon receipt of the fees payable under Article 80(2), the receiving competent authority shall accept the application and inform the applicant accordingly, indicating the date of the acceptance.

2.

Within 30 days of acceptance, the receiving competent authority shall validate the application if it complies with the following requirements:

(a)

the relevant information referred to in Article 20 has been submitted; and

(b)

the applicant states that it has not applied to any other competent authority for a national authorisation for the same biocidal product for the same use(s).

In the context of the validation referred to in the first subparagraph, the receiving competent authority shall not make an assessment of the quality or the adequacy of the data or justifications submitted.

3.

Where the receiving competent authority considers that the application is incomplete, it shall inform the applicant as to what additional information is required for the validation of the application and shall set a reasonable time limit for the submission of that information. That time limit shall not normally exceed 90 days.

The receiving competent authority shall, within 30 days of receipt of the additional information, validate the application if it determines that the additional information submitted is sufficient to comply with the requirements laid down in paragraph 2.

The receiving competent authority shall reject the application if the applicant fails to submit the requested information within the deadline and shall inform the applicant accordingly.

4.

Where the Register for Biocidal Products referred to in Article 71 shows that a competent authority other than the receiving competent authority is examining an application relating to the same biocidal product or has already authorised the same biocidal product, the receiving competent authority shall decline to evaluate the application. In that event, the receiving competent authority shall inform the applicant of the possibility of seeking mutual recognition in accordance with Article 33 or 34.

5.

If paragraph 3 does not apply and the receiving competent authority considers that the application is complete, it shall validate the application and without delay inform the applicant accordingly, indicating the date of the validation.

The 10 that are cited most themselves, of 11.

  • Commission Implementing Regulation (EU) No 414/2013 of 6 May 2013 specifying a procedure…3Law

    … за разрешение на идентичен продукт се подават в съответствие с член 29, параграф 1 от Регламент (ЕС) № 528/2012 до компетентния орган, …

  • The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Am…1372Law

    … The application for mutual recognition shall be treated as having been made under Article 29 of this Regulation and the time limits under Articles 29 and 30 shall be suspended until— (a) the date on which the applicant resubmits the …

  • The Chemicals (Health and Safety) and Genetically Modified Organisms (Contained Use) (Am…Law

    … applies where— (a) an application was made before IP completion day to the United Kingdom competent authority under Articles 29 or 31 of Regulation (EU) No 528/2012, and (b) a decision was not made before IP completion day. 2. The …

  • Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012…95dLaw

    … applies where— (a) an application was made before IP completion day to the United Kingdom competent authority under Articles 29 or 31 of Regulation (EU) No 528/2012, and (b) a decision was not made before IP completion day. 2. The …

  • Judgment of the General Court (Ninth Chamber) of 17 January 2024. Troy Chemical Company BV and Troy Corp. v European Commission.Decision

    As a result, applicants for authorisation of biocidal products containing carbendazim exclusively or for which it was the last approved existing substance had almost a year to submit their dossiers. Furthermore, according to Articles 29, …

    17 Jan 2024 · 62021TJ0297

  • BMUKNBGebVLaw

    … 88/2014 | 101 400,00 1.2 | Nationale Produktzulassungen | 1.2.1 | Nationale Zulassung nach Artikel 29 der Verordnung (EU) Nr. 528/2012 oder Vorläufige Zulassung nach Artikel 55 Absatz 2 der Verordnung (EU) Nr. 528/2012 | 1.2.1.1 | eines …

  • Opinion of Advocate General Rantos delivered on 20 May 2021. Biofa AG v Sikma D. Vertriebs GmbH und Co. KG.Decision

    Unlike the procedure for the approval of active substances, Regulation No 528/2012 makes provision for a number of different ways of obtaining authorisation for biocidal products, namely national authorisation (Chapter VI, Articles 29 to …

    20 May 2021 · 62020CC0029

  • Regulation (EU) 2016/18021Law

    … разрешение на идентичен продукт се подават в съответствие с член 29, параграф 1 от Регламент (ЕС) № 528/2012 до компетентния орган в …

  • Arrêté du 4 juin 2026 fixant le montant de la rémunération due au titre de l'approbation…2Law

    Dans le cas où une demande n'est pas validée, est rejetée ou est retirée avant d'être validée conformément aux articles 7, 26, 29, 33, 34 ou 43 du règlement (UE) n° 528/2012 ou aux articles 7, 8 ou 13 du règlement d'exécution …

  • BMUKNBGebVLaw